North America Gene Synthesis Market

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Gene Synthesis Market, by Method
1.4.2 North America Gene Synthesis Market, by Service Type
1.4.3 North America Gene Synthesis Market, by Application
1.4.4 North America Gene Synthesis Market, by End User
1.4.5 North America Gene Synthesis Market, by Country
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market composition and scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Acquisition and Mergers
3.2.2 Partnerships, Collaborations and Agreements
3.2.3 Product Launches and Product Expansions
3.2.4 Geographical Expansions
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2017-2021)
3.3.2 Key Strategic Move: (Acquisitions and Mergers: 2017, Dec - 2021, Nov) Leading Players
3.3.3 Key Strategic Move: (Partnerships, Collaborations, and Agreements: 2017, Jul - 2021, Aug) Leading Players

Chapter 4. North America Gene Synthesis Market by Method
4.1 North America Solid-phase Synthesis Market by Country
4.2 North America Chip-based Synthesis Market by Country
4.3 North America PCR-based Enzyme Synthesis Market by Country

Chapter 5. North America Gene Synthesis Market by Service Type
5.1 North America Antibody DNA Synthesis Market by Country
5.2 North America Viral DNA Synthesis Market by Country
5.3 North America Others Market by Country

Chapter 6. North America Gene Synthesis Market by Application
6.1 North America Gene & Cell Therapy Development Market by Country
6.2 North America Vaccine Development Market by Country
6.3 North America Disease Diagnosis Market by Country
6.4 North America Others Market by Country

Chapter 7. North America Gene Synthesis Market by End User
7.1 North America Academic & Government Research Institutes Market by Country
7.2 North America Biotechnology & Pharmaceutical Companies Market by Country
7.3 North America Contract Research Organizations Market by Country

Chapter 8. North America Gene Synthesis Market by Country
8.1 US Gene Synthesis Market
8.1.1 US Gene Synthesis Market by Method
8.1.2 US Gene Synthesis Market by Service Type
8.1.3 US Gene Synthesis Market by Application
8.1.4 US Gene Synthesis Market by End User
8.2 Canada Gene Synthesis Market
8.2.1 Canada Gene Synthesis Market by Method
8.2.2 Canada Gene Synthesis Market by Service Type
8.2.3 Canada Gene Synthesis Market by Application
8.2.4 Canada Gene Synthesis Market by End User
8.3 Mexico Gene Synthesis Market
8.3.1 Mexico Gene Synthesis Market by Method
8.3.2 Mexico Gene Synthesis Market by Service Type
8.3.3 Mexico Gene Synthesis Market by Application
8.3.4 Mexico Gene Synthesis Market by End User
8.4 Rest of North America Gene Synthesis Market
8.4.1 Rest of North America Gene Synthesis Market by Method
8.4.2 Rest of North America Gene Synthesis Market by Service Type
8.4.3 Rest of North America Gene Synthesis Market by Application
8.4.4 Rest of North America Gene Synthesis Market by End User

Chapter 9. Company Profiles
9.1 Genscript Biotech Corporation
9.1.1 Company Overview
9.1.2 Financial Analysis
9.1.3 Regional & Segmental Analysis
9.1.4 Research & Development Expenses
9.1.5 Recent strategies and developments:
9.1.5.1 Partnerships, Collaborations, and Agreements:
9.1.5.2 Product Launches and Product Expansions:
9.1.5.3 Acquisition and Mergers:
9.1.5.4 Geographical Expansions:
9.2 Thermo Fisher Scientific, Inc.
9.2.1 Company Overview
9.2.2 Financial Analysis
9.2.3 Segmental and Regional Analysis
9.2.4 Research & Development Expense
9.2.5 Recent strategies and developments:
9.2.5.1 Partnerships, Collaborations, and Agreements:
9.2.5.2 Acquisition and Mergers:
9.2.5.3 Geographical Expansions:
9.2.6 SWOT Analysis
9.3 Brooks Automation, Inc.
9.3.1 Company Overview
9.3.2 Financial Analysis
9.3.3 Regional & Segmental Analysis
9.3.4 Research & Development Expenses
9.3.5 Recent strategies and developments:
9.3.5.1 Acquisition and Mergers:
9.4 Boster Biological Technology
9.4.1 Company Overview
9.5 Twist Bioscience Corporation
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Regional & Segmental Analysis
9.5.4 Research & Development Expenses
9.5.5 Recent strategies and developments:
9.5.5.1 Partnerships, Collaborations, and Agreements:
9.5.5.2 Acquisition and Mergers:
9.5.5.3 Product Launches and Product Expansions:
9.5.5.4 Geographical Expansions:
9.6 Danaher Corporation
9.6.1 Company Overview
9.6.2 Financial Analysis
9.6.3 Segmental and Regional Analysis
9.6.4 Research & Development Expense
9.6.5 Recent strategies and developments:
9.6.5.1 Product Launches and Product Expansions:
9.6.5.2 Acquisition and Mergers:
9.6.5.3 Geographical Expansions:
9.7 Biomatik Corporation
9.7.1 Company Overview
9.8 ProteoGenix
9.8.1 Company Overview
9.9 ProMab Biotechnologies, Inc.
9.9.1 Company Overview
9.10. OriGene Technologies, Inc.
9.10.1 Company Overview


LIST OF TABLES
TABLE 1 NORTH AMERICA GENE SYNTHESIS MARKET, 2017 - 2020, USD MILLION
TABLE 2 NORTH AMERICA GENE SYNTHESIS MARKET, 2021 - 2027, USD MILLION
TABLE 3 ACQUISITION AND MERGERS- GENE SYNTHESIS MARKET
TABLE 4 PARTNERSHIPS, COLLABORATIONS AND AGREEMENTS- GENE SYNTHESIS MARKET
TABLE 5 PRODUCT LAUNCHES AND PRODUCT EXPANSIONS- GENE SYNTHESIS MARKET
TABLE 6 GEOGRAPHICAL EXPANSIONS- GENE SYNTHESIS MARKET
TABLE 7 NORTH AMERICA GENE SYNTHESIS MARKET BY METHOD, 2017 - 2020, USD MILLION
TABLE 8 NORTH AMERICA GENE SYNTHESIS MARKET BY METHOD, 2021 - 2027, USD MILLION
TABLE 9 NORTH AMERICA SOLID-PHASE SYNTHESIS MARKET BY COUNTRY, 2017 - 2020, USD MILLION
TABLE 10 NORTH AMERICA SOLID-PHASE SYNTHESIS MARKET BY COUNTRY, 2021 - 2027, USD MILLION
TABLE 11 NORTH AMERICA CHIP-BASED SYNTHESIS MARKET BY COUNTRY, 2017 - 2020, USD MILLION
TABLE 12 NORTH AMERICA CHIP-BASED SYNTHESIS MARKET BY COUNTRY, 2021 - 2027, USD MILLION
TABLE 13 NORTH AMERICA PCR-BASED ENZYME SYNTHESIS MARKET BY COUNTRY, 2017 - 2020, USD MILLION
TABLE 14 NORTH AMERICA PCR-BASED ENZYME SYNTHESIS MARKET BY COUNTRY, 2021 - 2027, USD MILLION
TABLE 15 NORTH AMERICA GENE SYNTHESIS MARKET BY SERVICE TYPE, 2017 - 2020, USD MILLION
TABLE 16 NORTH AMERICA GENE SYNTHESIS MARKET BY SERVICE TYPE, 2021 - 2027, USD MILLION
TABLE 17 NORTH AMERICA ANTIBODY DNA SYNTHESIS MARKET BY COUNTRY, 2017 - 2020, USD MILLION
TABLE 18 NORTH AMERICA ANTIBODY DNA SYNTHESIS MARKET BY COUNTRY, 2021 - 2027, USD MILLION
TABLE 19 NORTH AMERICA VIRAL DNA SYNTHESIS MARKET BY COUNTRY, 2017 - 2020, USD MILLION
TABLE 20 NORTH AMERICA VIRAL DNA SYNTHESIS MARKET BY COUNTRY, 2021 - 2027, USD MILLION
TABLE 21 NORTH AMERICA OTHERS MARKET BY COUNTRY, 2017 - 2020, USD MILLION
TABLE 22 NORTH AMERICA OTHERS MARKET BY COUNTRY, 2021 - 2027, USD MILLION
TABLE 23 NORTH AMERICA GENE SYNTHESIS MARKET BY APPLICATION, 2017 - 2020, USD MILLION
TABLE 24 NORTH AMERICA GENE SYNTHESIS MARKET BY APPLICATION, 2021 - 2027, USD MILLION
TABLE 25 NORTH AMERICA GENE & CELL THERAPY DEVELOPMENT MARKET BY COUNTRY, 2017 - 2020, USD MILLION
TABLE 26 NORTH AMERICA GENE & CELL THERAPY DEVELOPMENT MARKET BY COUNTRY, 2021 - 2027, USD MILLION
TABLE 27 NORTH AMERICA VACCINE DEVELOPMENT MARKET BY COUNTRY, 2017 - 2020, USD MILLION
TABLE 28 NORTH AMERICA VACCINE DEVELOPMENT MARKET BY COUNTRY, 2021 - 2027, USD MILLION
TABLE 29 NORTH AMERICA DISEASE DIAGNOSIS MARKET BY COUNTRY, 2017 - 2020, USD MILLION
TABLE 30 NORTH AMERICA DISEASE DIAGNOSIS MARKET BY COUNTRY, 2021 - 2027, USD MILLION
TABLE 31 NORTH AMERICA OTHERS MARKET BY COUNTRY, 2017 - 2020, USD MILLION
TABLE 32 NORTH AMERICA OTHERS MARKET BY COUNTRY, 2021 - 2027, USD MILLION
TABLE 33 NORTH AMERICA GENE SYNTHESIS MARKET BY END USER, 2017 - 2020, USD MILLION
TABLE 34 NORTH AMERICA GENE SYNTHESIS MARKET BY END USER, 2021 - 2027, USD MILLION
TABLE 35 NORTH AMERICA ACADEMIC & GOVERNMENT RESEARCH INSTITUTES MARKET BY COUNTRY, 2017 - 2020, USD MILLION
TABLE 36 NORTH AMERICA ACADEMIC & GOVERNMENT RESEARCH INSTITUTES MARKET BY COUNTRY, 2021 - 2027, USD MILLION
TABLE 37 NORTH AMERICA BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES MARKET BY COUNTRY, 2017 - 2020, USD MILLION
TABLE 38 NORTH AMERICA BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES MARKET BY COUNTRY, 2021 - 2027, USD MILLION
TABLE 39 NORTH AMERICA CONTRACT RESEARCH ORGANIZATIONS MARKET BY COUNTRY, 2017 - 2020, USD MILLION
TABLE 40 NORTH AMERICA CONTRACT RESEARCH ORGANIZATIONS MARKET BY COUNTRY, 2021 - 2027, USD MILLION
TABLE 41 NORTH AMERICA GENE SYNTHESIS MARKET BY COUNTRY, 2017 - 2020, USD MILLION
TABLE 42 NORTH AMERICA GENE SYNTHESIS MARKET BY COUNTRY, 2021 - 2027, USD MILLION
TABLE 43 US GENE SYNTHESIS MARKET, 2017 - 2020, USD MILLION
TABLE 44 US GENE SYNTHESIS MARKET, 2021 - 2027, USD MILLION
TABLE 45 US GENE SYNTHESIS MARKET BY METHOD, 2017 - 2020, USD MILLION
TABLE 46 US GENE SYNTHESIS MARKET BY METHOD, 2021 - 2027, USD MILLION
TABLE 47 US GENE SYNTHESIS MARKET BY SERVICE TYPE, 2017 - 2020, USD MILLION
TABLE 48 US GENE SYNTHESIS MARKET BY SERVICE TYPE, 2021 - 2027, USD MILLION
TABLE 49 US GENE SYNTHESIS MARKET BY APPLICATION, 2017 - 2020, USD MILLION
TABLE 50 US GENE SYNTHESIS MARKET BY APPLICATION, 2021 - 2027, USD MILLION
TABLE 51 US GENE SYNTHESIS MARKET BY END USER, 2017 - 2020, USD MILLION
TABLE 52 US GENE SYNTHESIS MARKET BY END USER, 2021 - 2027, USD MILLION
TABLE 53 CANADA GENE SYNTHESIS MARKET, 2017 - 2020, USD MILLION
TABLE 54 CANADA GENE SYNTHESIS MARKET, 2021 - 2027, USD MILLION
TABLE 55 CANADA GENE SYNTHESIS MARKET BY METHOD, 2017 - 2020, USD MILLION
TABLE 56 CANADA GENE SYNTHESIS MARKET BY METHOD, 2021 - 2027, USD MILLION
TABLE 57 CANADA GENE SYNTHESIS MARKET BY SERVICE TYPE, 2017 - 2020, USD MILLION
TABLE 58 CANADA GENE SYNTHESIS MARKET BY SERVICE TYPE, 2021 - 2027, USD MILLION
TABLE 59 CANADA GENE SYNTHESIS MARKET BY APPLICATION, 2017 - 2020, USD MILLION
TABLE 60 CANADA GENE SYNTHESIS MARKET BY APPLICATION, 2021 - 2027, USD MILLION
TABLE 61 CANADA GENE SYNTHESIS MARKET BY END USER, 2017 - 2020, USD MILLION
TABLE 62 CANADA GENE SYNTHESIS MARKET BY END USER, 2021 - 2027, USD MILLION
TABLE 63 MEXICO GENE SYNTHESIS MARKET, 2017 - 2020, USD MILLION
TABLE 64 MEXICO GENE SYNTHESIS MARKET, 2021 - 2027, USD MILLION
TABLE 65 MEXICO GENE SYNTHESIS MARKET BY METHOD, 2017 - 2020, USD MILLION
TABLE 66 MEXICO GENE SYNTHESIS MARKET BY METHOD, 2021 - 2027, USD MILLION
TABLE 67 MEXICO GENE SYNTHESIS MARKET BY SERVICE TYPE, 2017 - 2020, USD MILLION
TABLE 68 MEXICO GENE SYNTHESIS MARKET BY SERVICE TYPE, 2021 - 2027, USD MILLION
TABLE 69 MEXICO GENE SYNTHESIS MARKET BY APPLICATION, 2017 - 2020, USD MILLION
TABLE 70 MEXICO GENE SYNTHESIS MARKET BY APPLICATION, 2021 - 2027, USD MILLION
TABLE 71 MEXICO GENE SYNTHESIS MARKET BY END USER, 2017 - 2020, USD MILLION
TABLE 72 MEXICO GENE SYNTHESIS MARKET BY END USER, 2021 - 2027, USD MILLION
TABLE 73 REST OF NORTH AMERICA GENE SYNTHESIS MARKET, 2017 - 2020, USD MILLION
TABLE 74 REST OF NORTH AMERICA GENE SYNTHESIS MARKET, 2021 - 2027, USD MILLION
TABLE 75 REST OF NORTH AMERICA GENE SYNTHESIS MARKET BY METHOD, 2017 - 2020, USD MILLION
TABLE 76 REST OF NORTH AMERICA GENE SYNTHESIS MARKET BY METHOD, 2021 - 2027, USD MILLION
TABLE 77 REST OF NORTH AMERICA GENE SYNTHESIS MARKET BY SERVICE TYPE, 2017 - 2020, USD MILLION
TABLE 78 REST OF NORTH AMERICA GENE SYNTHESIS MARKET BY SERVICE TYPE, 2021 - 2027, USD MILLION
TABLE 79 REST OF NORTH AMERICA GENE SYNTHESIS MARKET BY APPLICATION, 2017 - 2020, USD MILLION
TABLE 80 REST OF NORTH AMERICA GENE SYNTHESIS MARKET BY APPLICATION, 2021 - 2027, USD MILLION
TABLE 81 REST OF NORTH AMERICA GENE SYNTHESIS MARKET BY END USER, 2017 - 2020, USD MILLION
TABLE 82 REST OF NORTH AMERICA GENE SYNTHESIS MARKET BY END USER, 2021 - 2027, USD MILLION
TABLE 83 KEY INFORMATION - GENSCRIPT BIOTECH CORPORATION
TABLE 84 KEY INFORMATION - THERMO FISHER SCIENTIFIC, INC.
TABLE 85 KEY INFORMATION - BROOKS AUTOMATION, INC
TABLE 86 KEY INFORMATION - BOSTER BIOLOGICAL TECHNOLOGY
TABLE 87 KEY INFORMATION - TWIST BIOSCIENCE CORPORATION
TABLE 88 KEY INFORMATION - DANAHER CORPORATION
TABLE 89 KEY INFORMATION - BIOMATIK CORPORATION
TABLE 90 KEY INFORMATION - PROTEOGENIX
TABLE 91 KEY INFORMATION - PROMAB BIOTECHNOLOGIES, INC.
TABLE 92 KEY INFORMATION - ORIGENE TECHNOLOGIES, INC.

LIST OF FIGURES
FIG 1 METHODOLOGY FOR THE RESEARCH
FIG 2 KBV CARDINAL MATRIX
FIG 3 KEY LEADING STRATEGIES: PERCENTAGE DISTRIBUTION (2017-2021)
FIG 4 KEY STRATEGIC MOVE: (ACQUISITIONS AND MERGERS: 2017, DEC - 2021, NOV) LEADING PLAYERS
FIG 5 KEY STRATEGIC MOVE: (PARTNERSHIPS, COLLABORATIONS, AND AGREEMENTS: 2017, JUL - 2021, AUG) LEADING PLAYERS
FIG 6 RECENT STRATEGIES AND DEVELOPMENTS: GENSCRIPT BIOTECH CORPORATION
FIG 7 RECENT STRATEGIES AND DEVELOPMENTS: THERMO FISHER SCIENTIFIC, INC.
FIG 8 SWOT ANALYSIS: THERMO FISHER SCIENTIFIC, INC.
FIG 9 RECENT STRATEGIES AND DEVELOPMENTS: TWIST BIOSCIENCE CORPORATION
FIG 10 RECENT STRATEGIES AND DEVELOPMENTS: DANAHER CORPORATION